Plk1 expression leads to poor prognosis in lung, bladder, and kidney clear cell carcinomas patients, whereas in patients suffering from thymoma, lung squamous cell carcinoma or rectum adenocarcinoma, Plk1 higher levels seem to indicate a much better prognosis. This evidence concerns the gene PLK1 and thymoma.